Hong Kong has served as a pivotal gateway to both mainland China and global markets for the burgeoning biotech industry. The city has established the roadmap to become a hub for biotechnology following the recent years of government announcements outlining strategic initiatives in the life sciences sector. Leveraging the numerous funding opportunities for startups, favorable new policies tailored for the biotech sector, and top-notch R&D infrastructure, Hong Kong stands poised to be an international biotechnology hub. Pioneering this effort is Hong Kong Science and Technology Parks Corporation (HKSTP), home to over 260 biotech companies. As the only biotech ecosystem in Hong Kong, it offers an all-round platform to facilitate patient-centric biomedical innovations and accelerate market expansion. Beyond scientific excellence, talent and financial backing, Hong Kong’s vibrant biotech community stands out as a unique conduit to the global markets. Esteemed speakers and panelists in this session will share their insights on the strategies and initiatives driving biotech advancement in Hong Kong and their impact on the global stage.